Heart and Vascular CenterSM - The Christ Hospital
Heart and Vascular CenterSM - The Christ Hospital
Heart and Vascular CenterSM - The Christ Hospital
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
<strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> <strong>CenterSM</strong><br />
Cincinnati, Ohio<br />
Annual Report<br />
2008
Dear Colleagues <strong>and</strong> Friends<br />
Thank you for your interest in <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center. Over the past four years, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> has been consistently<br />
recognized as a “Top 50” hospital for heart <strong>and</strong> heart surgery by U.S.News & World Report <strong>and</strong> as a Solucient “Top 100 <strong>Heart</strong> <strong>Hospital</strong>” for eight<br />
consecutive years. With our doctor-driven, patient-centered programs for cardiovascular disease management, we provide exceptional patient care.<br />
When patients come to <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>, they can expect to find state-of-the-art heart care, which combines leading edge technology with<br />
compassionate, personalized attention. Please take a moment to learn about several highlights in cardiovascular care at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong><br />
<strong>Vascular</strong> Center during the past year.<br />
Faster <strong>and</strong> better treatment for heart attack victims<br />
Successful heart programs around the country must provide rapid treatment for heart attack patients. This minimizes time delay from hospital arrival to<br />
definitive treatment with angioplasty to open the occluded coronary artery. <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center was one of the first centers<br />
in the United States to become fully integrated with pre-hospital emergency medical systems that transmit a 12-lead EKG directly to our emergency<br />
physician. This process improvement initiative, which began in 2005, dramatically reduced the time delay to heart attack treatment. We received<br />
the Anthem Quality <strong>Hospital</strong> award for the shortest “door to balloon” time delay in the state of Ohio in 2007. By using pre-hospital diagnosis <strong>and</strong> a<br />
multidisclipinary team approach, we consistently provide treatment times that rank in the top 10 percent of the United States.<br />
<strong>The</strong> Carl H. & Edyth Lindner <strong>Heart</strong> Failure Treatment Center<br />
Patients suffering from congestive heart failure now have a novel opportunity for comprehensive evaluation <strong>and</strong> treatment that extends even beyond<br />
the confines of the hospital. <strong>The</strong> Lindner <strong>Heart</strong> Failure Treatment Center provides dedicated nurse practitioners to implement quality-assured clinical<br />
care; a dedicated congestive heart failure nurse-educator to teach both patients <strong>and</strong> staff; <strong>and</strong> a <strong>Heart</strong> Link nurse to provide patient follow-up after<br />
hospital discharge, assuring that each patient receives the appropriate medications <strong>and</strong> follow-up care from his or her personal cardiologist <strong>and</strong>/or<br />
primary care physician. In addition, our patients are offered access to leading edge technologies <strong>and</strong> treatments involving new medicines <strong>and</strong> medical<br />
devices, as well as adult stem cell regenerative therapies.<br />
Most procedures performed with the best outcomes<br />
With the highest annual cardiovascular procedural volumes in the Ohio, Kentucky <strong>and</strong> Indiana region, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center<br />
is a recognized leader in cardiovascular care, <strong>and</strong> consistently ranks among the best centers in the U.S. for cardiac surgical mortality rates. We have<br />
long been a national <strong>and</strong> international leader in percutaneous coronary intervention <strong>and</strong> are pioneers in new stent technologies. We believe that the<br />
meticulous, personalized approach to every detail of patient care by our outst<strong>and</strong>ing staff translates into excellent clinical outcomes.<br />
Education <strong>and</strong> research<br />
One of the hallmarks of every top cardiovascular program in the United States is a focus on medical education <strong>and</strong> research. <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
<strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center, in collaboration with <strong>The</strong> Lindner Clinical Trial Center, has distinguished itself internationally. In fact, during the past year,<br />
several of our physicians have presented late breaking clinical trial results at international medical conferences. As international principal investigators<br />
for their respective trials, Dr. <strong>The</strong>odore Chow presented the results of the MASTER 1 trial at the 2007 Annual American <strong>Heart</strong> Association meeting in<br />
Orl<strong>and</strong>o, Florida. Dr. Eugene Chung presented the results of the PROSPECT trial at the 2007 Annual Meeting of the <strong>Heart</strong> Failure Society of America<br />
in Washington, D.C., <strong>and</strong> I had the opportunity to present results from the CoStar II trial at the 2007 annual Euro-PCR meeting in Barcelona, Spain, as<br />
well as the AMETHYST trial at the 2007 annual Transcatheter Cardiovascular <strong>The</strong>rapeutics meeting in Washington, D.C. Our distinguished physician<br />
staff has performed over 900 clinical research protocols, which have culminated in more than 600 peer-reviewed medical publications. In addition, we<br />
provide accredited educational programs for physicians, nurses <strong>and</strong> allied medical personnel. <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> has formal affiliations with Ohio State<br />
University to train cardiovascular fellows specializing in peripheral vascular intervention, <strong>and</strong> the University of Cincinnati to train cardiovascular fellows in<br />
advanced CT <strong>and</strong> MRI cardiovascular imaging.<br />
With commitments to excellence in patient care <strong>and</strong> to innovations in technology <strong>and</strong> wellness programs, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> has set the st<strong>and</strong>ard for<br />
quality cardiovascular care in the region. We are very pleased to share our report with you <strong>and</strong> welcome your feedback <strong>and</strong> comments.<br />
2<br />
Sincerely,<br />
Dean J. Kereiakes, M.D., F.A.C.C.<br />
Medical Director<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center
Stephanie Bolden-Harris<br />
has experienced the quality<br />
cardiovascular wellness<br />
programs at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>.<br />
4<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>
Patient Satisfaction<br />
For the twelfth consecutive year, National<br />
Research Corporation (NRC) has named<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> a Consumer Choice<br />
Award winner. Consumers in the Cincinnati<br />
market have rated <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> as<br />
the hospital most preferred for best quality,<br />
image <strong>and</strong> overall service, as announced in<br />
Modern Healthcare magazine.<br />
This testimony of our patient preference is prevalent in our “Press, Ganey” patient<br />
satisfaction scores. We reached an all-time overall high in 2007 at 87.1 (top 12 percent<br />
nationally). <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center monitors patient satisfaction,<br />
constantly strives for improvement <strong>and</strong> sees patient satisfaction as a cornerstone for<br />
service excellence.<br />
5
Cardiovascular Surgery<br />
Cardiac surgeons at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
<strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> are the most experienced<br />
in the region. As the national trend for<br />
open-heart procedure volume continues to<br />
decrease due to better medical therapy <strong>and</strong><br />
improved non-surgical interventions, new<br />
surgical procedures are being performed<br />
to treat patients with the highest acuity,<br />
thus providing the most comprehensive<br />
cardiovascular care for our patients.<br />
Surgical Ablation<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> heart surgeons are performing surgical cardiac ablation procedures using<br />
the Epicor Cardiac Ablation System. This procedure, which uses high intensity focused<br />
ultrasound (HIFU) waves, is the most effective surgical treatment for atrial fibrillation,<br />
eliminating arrhythmia in nearly 97 percent of patients. With the new Epicor technology, the<br />
heart-lung bypass machine is not required <strong>and</strong> there are no hot or cold temperatures used to<br />
ablate the electrical cells, which results in faster recovery.<br />
Robotic Transmyocardial Revascularization<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> cardiac surgeons have performed multiple robotic-assisted<br />
transmyocardial revascularization procedures. Robotic Transmyocardial Revascularization<br />
(Robotic TMR) is a minimally invasive treatment for patients suffering from severe angina.<br />
It uses the combined advantages of the daVinci Robotic Surgical System <strong>and</strong> the<br />
Cardiogenesis TMR laser. <strong>The</strong> Cardiogenesis laser creates small channels through the wall<br />
of the left ventricle of the heart, which increases oxygen delivered to the heart muscle. <strong>The</strong><br />
success rate of Robotic TMR for reducing angina is 75 percent, compared with 30 percent<br />
using other treatment modalities.<br />
Cardiovascular Surgeries: CABG,<br />
Valves, Carotids, Abdominal Aorta<br />
1000<br />
986<br />
974<br />
927<br />
866<br />
750<br />
500<br />
250<br />
6<br />
0<br />
CY04 CY05 CY06 CY07<br />
CY = calendar year
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
Ronald Wright, our first robotic<br />
transmyocardial revascularization<br />
patient in Ohio, has experienced<br />
marked improvement in his angina.<br />
7
Interventional Cardiology<br />
During 2008, interventional cardiology at<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong><br />
Center was at the national forefront.<br />
Significant advances were made in coronary<br />
<strong>and</strong> peripheral vascular intervention as well<br />
as in treatments for structural heart disease.<br />
New Procedures<br />
<strong>Christ</strong> <strong>Hospital</strong> cardiologists, working in conjunction with Cincinnati Children’s <strong>Hospital</strong> Medical Center<br />
personnel, were the first in the U.S. to perform the percutaneous closure of a paravalvular leak from a<br />
mechanical mitral valve. This patient had undergone four previous valve replacement surgeries <strong>and</strong> was<br />
not a c<strong>and</strong>idate for additional surgery.<br />
Capitalizing on our extensive experience with percutaneous closure of both atrial septal defects <strong>and</strong>/or<br />
patent foramen ovale using the Amplatzer device, our physicians used this same device to seal the<br />
life-threatening paravalvular leak. This ground-breaking, life saving procedure was performed without<br />
requiring open heart surgery.<br />
Drug-Eluting Stents<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>and</strong> <strong>The</strong> Lindner Clinical Trial Center have been the top enrolling centers in the world<br />
for the CoStar II trial of a novel drug-eluting stent platform that employs a bioresorbable polymer, <strong>and</strong><br />
are also top enrollers in the SPIRIT IV <strong>and</strong> PERSEUS trials of second <strong>and</strong> third generation drug-eluting<br />
stents. <strong>Christ</strong> <strong>Hospital</strong> physicians have served as national/international principal investigators for these<br />
multicenter trials. <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> is the only center in the Tristate region to have “mini” drug-eluting<br />
stents (2.25 mm diameter) designed specifically to treat small coronary arteries.<br />
Hemodynamic Support<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>and</strong> <strong>The</strong> Lindner Clinical Trial Center are evaluating the Impella Recover ®<br />
Hemodynamic Support System to treat patients at extreme high risk during angioplasty or with<br />
severe depression in heart muscle function. A small pump on a catheter is inserted during a cardiac<br />
catheterization procedure <strong>and</strong> is capable of supporting vital functions even when the heart stops<br />
beating temporarily.<br />
140<br />
Door-to-Balloon Time<br />
January 2005 - December 2007 (Median - minutes)<br />
120<br />
100<br />
110 109<br />
115<br />
108<br />
Target = 90 minutes<br />
8<br />
80<br />
60<br />
40<br />
20<br />
0<br />
90<br />
74<br />
68<br />
73<br />
71<br />
58<br />
55<br />
35<br />
Q1CY05 Q2CY05 Q3CY05 Q4CY05 Q1CY06 Q2CY06 Q3CY06 Q4CY06 Q1CY07 Q2CY07 Q3CY07 Q4CY07<br />
Q = quarter<br />
CY = calendar year
Adult Stem Cell <strong>and</strong> Growth Factor Regenerative <strong>The</strong>rapies<br />
In collaboration with <strong>The</strong> Lindner Clinical Trial Center, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> physicians have participated<br />
in three innovative adult stem cell trials involving either circulating or bone marrow derived progenitor<br />
cells or skeletal myoblasts. <strong>The</strong>se studies have evaluated safety <strong>and</strong> efficacy of adult stem cells to<br />
relieve refractory, intractable anginal chest pain or to regenerate functional heart muscle to improve<br />
heart function.<br />
Skeletal myoblasts derived from a skeletal muscle (leg) biopsy are either injected during bypass<br />
surgery or percutaneously by direct intramyocardial injection using the Noga Myostar injection catheter<br />
during a cardiac catheterization. In a study of patients who have suffered a heart attack, bone marrowderived<br />
cells were infused directly into the infarct-related coronary artery supplying a region of more<br />
recent (
Congestive <strong>Heart</strong> Failure<br />
As the U.S. population ages, the number<br />
of patients with congestive heart failure<br />
(CHF) continues to increase. In 2007,<br />
<strong>The</strong> Carl H. & Edyth Lindner <strong>Heart</strong><br />
Failure Treatment Center, a 28-bed<br />
unit dedicated to improving the care of<br />
patients with heart failure, was opened at<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>. This unique facility<br />
utilizes a multidisciplinary approach<br />
<strong>and</strong> leading-edge technologies to enhance<br />
patient outcomes.<br />
New Treatments for the Failing <strong>Heart</strong><br />
<strong>The</strong> Carl & Edyth Lindner <strong>Heart</strong> Failure Treatment Center has the most experience in the region with ultrafiltration,<br />
a technique that removes excess fluid build-up in heart failure patients. Ultrafiltration can result in<br />
more rapid relief of shortness of breath <strong>and</strong> faster resolution of edema. Our physicians have been leaders<br />
in the use of biventricular pacemakers to improve pump function <strong>and</strong> have pioneered echocardiographic<br />
<strong>and</strong> MRI techniques to predict the likelihood of improvement. Working collaboratively with <strong>The</strong> Lindner<br />
Clinical Trial Center, our physicians performed the first study of biventricular pacing to improve heart function<br />
following major heart attack. Recently, a nitinol wrap (Paracor) that is surgically placed around the heart to<br />
prevent progressive heart enlargement as part of the PEERLESS-HF trial is being evaluated.<br />
<strong>The</strong> <strong>Heart</strong> Link Program<br />
<strong>Heart</strong> Link is a hospital-to-home patient education <strong>and</strong> compliance program that was implemented in June<br />
2007. <strong>Heart</strong> Link is aimed at assuring longer-term patient treatment benefit <strong>and</strong> reducing the likelihood of<br />
hospital readmission for heart failure. Since its inception, <strong>Heart</strong> Link has increased patient satisfaction <strong>and</strong><br />
increased compliance with prescribed treatments <strong>and</strong> medications <strong>and</strong> has resulted in better outcomes for<br />
our patients. <strong>The</strong> <strong>Heart</strong> Link program was named one of the Greater Cincinnati Health Council’s 2008 Best<br />
Innovative Healthcare Solutions.<br />
Congestive <strong>Heart</strong> Failure Clinic<br />
Many patients with CHF do not have health insurance <strong>and</strong> are unable to pay for follow-up appointments or<br />
medications. In order to proactively care for these patients, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> opened the Congestive <strong>Heart</strong><br />
Failure Clinic in December 2007. <strong>The</strong> clinic’s goal is to provide comprehensive, quality care for patients with<br />
CHF using a team-based approach. A CHF specialist, internal medicine residents, pharmacists <strong>and</strong> others<br />
work together to improve the patient’s underst<strong>and</strong>ing of the disease process <strong>and</strong> to improve his/her quality<br />
of life. <strong>The</strong> advantages of using the CHF clinic include: care from CHF specialist physicians <strong>and</strong> nurses, a<br />
team approach to care, discounted medications <strong>and</strong> patient education.<br />
<strong>Heart</strong> Failure All-or-None Compliance Index<br />
10<br />
100%<br />
90%<br />
80%<br />
70%<br />
60%<br />
50%<br />
40%<br />
30%<br />
20%<br />
10%<br />
0%<br />
68.75<br />
68.75<br />
71.69<br />
88.00 88.78<br />
81.78<br />
73.33 76.60 76.32 78.91<br />
84.13<br />
82.86<br />
86.87<br />
83.84<br />
85.38<br />
84.62<br />
88.61<br />
86.42<br />
Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar<br />
06 06 06 06 07 07 07 07 08<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
National average
<strong>The</strong> <strong>Christ</strong> <strong>The</strong> <strong>Hospital</strong><br />
<strong>Christ</strong> Valvular <strong>and</strong><br />
Structural <strong>Heart</strong><br />
Disease<br />
Physicians at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> have the<br />
most experience in the region treating adult<br />
structural <strong>and</strong> congenital heart disease, including<br />
atrial septal defect <strong>and</strong> patent foramen ovale<br />
percutaneous closure.<br />
Balloon Aortic Valvuloplasty<br />
New procedures are emerging for the treatment<br />
of aortic valve stenosis. Our physicians have the<br />
most experience in the region performing balloon<br />
aortic valvuloplasty, <strong>and</strong> with <strong>The</strong> Lindner Clinical<br />
Trial Center, have been top enrollers in a multicenter<br />
national clinical trial (RADAR trial) that offers older<br />
patients at high risk for surgery a safer option to treat<br />
aortic valve stenosis. RADAR is evaluating balloon<br />
valvuloplasty followed by External Beam Radiation<br />
<strong>The</strong>rapy in an attempt to preserve the salutary effects<br />
of valvuloplasty.<br />
Our physicians have been involved in the<br />
development <strong>and</strong> evaluation of percutaneous<br />
techniques to replace the aortic valve as well.<br />
Clara Hayes was our first<br />
RADAR clinical trial patient.<br />
11
Henry Helton couldn’t walk 100 feet.<br />
He received a 3-lead pacemaker <strong>and</strong> is<br />
now enjoying spending time with his<br />
gr<strong>and</strong>children.<br />
12<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>
Electrophysiology (EP)<br />
In 2007, the electrophysiologists at <strong>The</strong><br />
<strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center<br />
performed a record number of pacemaker<br />
implants. Specializing in both device<br />
implantation <strong>and</strong> ablation, our EP labs offer<br />
the latest state-of-the-art technology <strong>and</strong><br />
expertise in the Greater Cincinnati area.<br />
MRI Compatible Pacemakers<br />
As part of a new clinical trial, physicians at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>and</strong> <strong>The</strong> Lindner<br />
Clinical Trial Center were among the first in the U.S. to implant a pacemaker<br />
specifically designed to be compatible with magnetic resonance imaging (MRI).<br />
<strong>The</strong> EnRhythm MRI SureScan pacing system consists of the dual-chamber<br />
EnRhythm MRI SureScan pacemaker <strong>and</strong> CapSureFix MRI SureScan pacing<br />
leads. <strong>The</strong> clinical trial is a prospective, r<strong>and</strong>omized, controlled, unblinded, multicenter<br />
study, involving 470 individuals. All patients in the trial receive an EnRhythm<br />
MRI SureScan pacing system, <strong>and</strong> two-thirds of the participants receive MRI scans.<br />
Ablations<br />
ICD Implants<br />
190<br />
180<br />
170<br />
160<br />
150<br />
140<br />
130<br />
120<br />
110<br />
100<br />
179<br />
171<br />
169<br />
160<br />
CY04 CY05 CY06 CY07<br />
700<br />
650<br />
600<br />
550<br />
500<br />
450<br />
400<br />
350<br />
300<br />
250<br />
200<br />
150<br />
100<br />
0<br />
674<br />
547<br />
470<br />
432<br />
CY04 CY05 CY06 CY07<br />
Pacemaker Implants<br />
500<br />
450<br />
400<br />
350<br />
300<br />
250<br />
200<br />
150<br />
100<br />
50<br />
0<br />
458<br />
365<br />
398<br />
384<br />
CY04 CY05 CY06 CY07<br />
CY = calendar year<br />
13
<strong>Vascular</strong> Services<br />
Endovascular Treatment<br />
With the Tristate’s largest endovascular<br />
program, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong><br />
<strong>Vascular</strong> Center is involved in multiple<br />
clinical trials for claudication <strong>and</strong><br />
critical limb ischemia including catheterbased<br />
plaque excision <strong>and</strong> other new<br />
technologies. <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> has<br />
been a leader in physician education with<br />
physician tutorials to teach endovascular<br />
strategies <strong>and</strong> techniques to physicians<br />
from around the world.<br />
Atherectomy<br />
Physicians at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center are performing a minimally invasive procedure<br />
called plaque excision/directional atherectomy that removes atherosclerotic blockages. <strong>The</strong> plaque excision<br />
system removes blockages from the leg arteries <strong>and</strong> restores blood flow to the legs, feet <strong>and</strong> toes. This<br />
system uses a tiny rotating blade to shave away plaque from inside the artery, which is then collected<br />
in the tip of the device <strong>and</strong> is removed from the patient. Through <strong>The</strong> Lindner Clinical Trial Center, many<br />
research trials have focused on the safety <strong>and</strong> efficacy of this device. In addition to plaque excision, orbital<br />
atherectomy can be performed to treat complex diffuse disease. This device has a tiny diamond grit “covered<br />
crown” tip, which rotates in an orbital motion to s<strong>and</strong> away plaque from inside the artery.<br />
Laser<br />
Laser technology is being used to treat peripheral artery disease (PAD). A small, fiberoptic catheter transmits<br />
bursts of cool ultraviolet energy through the flexible fibers in the catheter, which penetrate the plaque <strong>and</strong><br />
vaporize the blockage.<br />
Peripheral Stent Graft<br />
Smaller diameter stent grafts, some of which are bonded with heparin anticoagulant, are being used in the<br />
treatment of peripheral arterial disease. This device may prevent restenosis in the superficial femoral artery.<br />
Aortic Stent Grafts for Aortic Aneurysm Treatment<br />
<strong>The</strong> physicians of the <strong>Vascular</strong> Center have specific expertise in the repair of both abdominal <strong>and</strong> thoracic<br />
aortic aneurysms <strong>and</strong> provide surgical as well as catheter-based stent graft treatments. <strong>The</strong> area’s first<br />
stent graft repair of an abdominal aortic aneurysm was performed at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> by physicians who<br />
perform more stent graft procedures than any other hospital in the region.<br />
Diagnostic Peripheral<br />
Procedures<br />
Interventional Peripheral<br />
Procedures<br />
2400<br />
1200<br />
2200<br />
2000<br />
2213<br />
2150 2146<br />
2127<br />
1000<br />
800<br />
1094<br />
1084<br />
1137<br />
1035<br />
1800<br />
1600<br />
600<br />
1400<br />
400<br />
14<br />
1200<br />
1000<br />
CY04 CY05 CY06 CY07<br />
200<br />
0<br />
CY04 CY05 CY06 CY07<br />
CY = calendar year
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
An avid cyclist, John Sanford was suffering<br />
from a rare condition that reduced blood flow<br />
to his left leg. After receiving a peripheral<br />
CTA at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>, vascular surgeons<br />
diagnosed his condition <strong>and</strong> were able to treat<br />
him surgically. He is now back to cycling, <strong>and</strong><br />
his quality of life has significantly improved.<br />
15
James Sticklen, a historic car enthusiast,<br />
needed a carotid stent placement to<br />
alleviate his near total occlusion.<br />
16<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>
<strong>Vascular</strong> Services<br />
Neurointerventional Services<br />
<strong>The</strong> multidisciplinary team of vascular surgeons, interventional radiologists, neurointerventional<br />
radiologists <strong>and</strong> cardiologists with <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> vascular services has participated in numerous<br />
clinical trials in stroke prevention related to carotid artery disease. <strong>The</strong>y have been an important part<br />
of the l<strong>and</strong>mark National Institutes of Health-sponsored CREST trial, comparing carotid artery surgery<br />
to minimally invasive carotid artery stenting. <strong>The</strong>y are currently serving as principal investigators<br />
within the CHOICE <strong>and</strong> EMPiRE carotid stenting trials for high risk patients suffering from severe<br />
carotid artery blockages. <strong>The</strong> team is able to offer every available approach to carotid artery disease,<br />
enabling patients to receive truly individualized treatment.<br />
<strong>Vascular</strong> Surgery<br />
<strong>The</strong> vascular surgeons at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> perform both surgical <strong>and</strong> endovascular procedures to<br />
treat aortic aneurysms, carotid artery disease <strong>and</strong> lower extremity arterial occlusive disease.<br />
Wound Healing Center<br />
Arterial occlusive disease <strong>and</strong> accompanying leg ischemia are common conditions <strong>and</strong> can lead<br />
to claudication <strong>and</strong> gangrene as well as localized ulceration. Arterial insufficiency is rarely a stable<br />
condition <strong>and</strong> is almost always progressive, making it important to diagnose <strong>and</strong> treat as early as<br />
possible to avoid further tissue loss.<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> Wound Healing Center opened in January 2007 to provide treatment options for<br />
these patients. Treatments for PAD may include medical or surgical management. Once the primary<br />
arterial obstruction has been treated <strong>and</strong> blood flow restored, <strong>The</strong> Wound Healing Center provides<br />
multiple treatment options to facilitate complete healing of the external wound. <strong>The</strong>se include:<br />
debridement, leading-edge dressings <strong>and</strong> wraps, hyperbaric oxygen therapy, bio-engineered tissue<br />
substitutes, vacuum-assisted closure <strong>and</strong> platelet technologies.<br />
17
Clinical Research <strong>and</strong> Education<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> is affiliated with the internationally-known Lindner Clinical Trial Center.<br />
<strong>The</strong> Lindner Clinical Trial Center<br />
Physicians at <strong>The</strong> Lindner Clinical Trial Center have participated in more than 900 clinical trials<br />
(more than 100 active trials) working in conjunction with <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>. <strong>The</strong> leading-edge<br />
research ranges from medical therapy trials involving obesity, diabetes, metabolic syndrome,<br />
hypertension, hyperlipidemia as well as one of the most extensive interventional trial portfolios<br />
involving drug eluting stents/new interventional devices, adult stem cell protocols <strong>and</strong> structural<br />
heart disease devices.<br />
Principal Investigators<br />
In 2007, the physicians served as national <strong>and</strong> international principal investigators for several<br />
large, multicenter clinical trials <strong>and</strong> presented late-breaking clinical trial results at international<br />
meetings. <strong>The</strong>se included: <strong>The</strong>odore Chow, M.D., who presented the MASTER 1 Trial at the<br />
American <strong>Heart</strong> Association meeting; Eugene Chung, M.D., who presented the the PROSPECT 2<br />
trial at the <strong>The</strong> <strong>Heart</strong> Failure Society of America; <strong>and</strong> Dean Kereiakes, M.D., who presented<br />
both the COSTAR Trial 3,4 at the Euro-PCR <strong>and</strong> the AMETHYST 5 Trials <strong>and</strong> the Transcatheter<br />
Cardiovascular <strong>The</strong>rapeutics meeting.<br />
Medical Education<br />
<strong>The</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center holds accredited fellowship training affiliations with <strong>The</strong> Ohio<br />
State University in peripheral vascular intervention <strong>and</strong> with the University of Cincinnati in<br />
advanced imaging.<br />
<strong>The</strong> Carl <strong>and</strong> Edyth Lindner Center for Education <strong>and</strong> Research<br />
<strong>The</strong> Carl <strong>and</strong> Edyth Lindner Center for Research <strong>and</strong> Education is a not-for-profit organization,<br />
which also provides support <strong>and</strong> training for physician fellowships <strong>and</strong> preceptorships as well<br />
as general community education through public forums. Our physician preceptorships <strong>and</strong><br />
educational programs in peripheral vascular intervention <strong>and</strong> C.T. angiographic imaging are<br />
nationally recognized.<br />
For more information, please call 513-585-1777.<br />
1<br />
Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, Brown ML, Pu W, Benditt DG on behalf of the MASTER Trial<br />
Investigators. Does Microvolt T-Wave Alternans Testing Predict Ventricular Tachyarrhythmias In Patients with Ischemic Cardiomyopathy<br />
<strong>and</strong> Prophylactic Defibrillators?: <strong>The</strong> MASTER Trial. J Am Coll Cardiol (in press)<br />
2<br />
Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsa J III, St.<br />
John Sutton M, DeSutter J, Murillo J. Results of the predictors of response to CRT (PROSPECT) Trial. Circulation 2008;117:2608-16.<br />
18<br />
3<br />
Kereiakes DJ, Petersen JL, Batchelor WB, Fitzgerald PJ, Mehran R, Lansky A, Tsujino I, Schofer J. Dubois C, Verheye S, Cristea E, Garg J,<br />
Wijns W, Krucoff MW. Clinical And Angiographic Outcomes In Diabetic Patients Following Single Or Multivessel Stenting In <strong>The</strong> COSTAR<br />
II R<strong>and</strong>omized Trial. J Invas Cardiol 2008;20:335-341.<br />
4<br />
Krucoff WM, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA, Verheye<br />
S, Dubois CL, Gammmon R, Batchelor WB, O’Shaughnessy CD, Hermiller JB, Schofer J. Buchbinder M, Wijns W for the COSTAR II<br />
investigators group. Novel bioresorbable polymer paclitaxel eluting stent for the treatment of single <strong>and</strong> multivessel coronary disease:<br />
primary results of the Cobalt Chromium Stent with Antiproliferative for restenosis II (COSTAR II) study. J Am Coll Cardiol 2008;51:1543-52.<br />
5<br />
Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE. A Novel<br />
Filter-Based Distal Embolic Protection Device for Percutaneous Intervention of Saphenous Vein Graft Lesions: Results of the Amethyst<br />
R<strong>and</strong>omized Controlled Trial. J Am Coll Cardiol Intv 2008:1:248-257.
Imaging<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
<strong>The</strong> imaging division of <strong>The</strong> <strong>Christ</strong><br />
<strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center offers<br />
the latest in technology <strong>and</strong> expertise<br />
with a multidisciplinary team approach.<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>’s echocardiogram (echo) lab is<br />
accredited by <strong>The</strong> Intersocietal Commission for the<br />
Accreditation of Echocardiography Laboratories. All<br />
cardiologists who read echocardiograms are Level II<br />
or III credentialed <strong>and</strong> work with an all-digital system.<br />
Additionally, the peripheral vascular lab at <strong>The</strong> <strong>Christ</strong><br />
<strong>Hospital</strong> is accredited by <strong>The</strong> Intersocietal Commission<br />
for the Accreditation of <strong>Vascular</strong> Laboratories. <strong>The</strong><br />
tests are read by board-certified vascular surgeons<br />
utilizing digital technology. Our cardiac magnetic<br />
resonance imaging (MRI) laboratory utilizes the<br />
newest Siemens ® <strong>and</strong> General Electric ® scanners to<br />
provide the best imaging possible. Installed recently,<br />
3-D echocardiography <strong>and</strong> dyssynchrony assessment<br />
software programs provide clearer visualization <strong>and</strong> more<br />
accurate diagnosis.<br />
<strong>The</strong> multidisciplinary imaging team at <strong>The</strong> <strong>Christ</strong><br />
<strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center includes radiologists,<br />
interventional radiologists, cardiologists, vascular<br />
surgeons <strong>and</strong> an expert technical staff. Our team focuses<br />
on education with biweekly echo technologist lectures<br />
<strong>and</strong> monthly CT <strong>and</strong> MRI cardiology fellow lectures.<br />
Our imaging specialists host a h<strong>and</strong>s-on lecture series<br />
that provides ACC/AHA Level II <strong>and</strong> III credentialing<br />
<strong>and</strong> is attended by physicians throughout the country.<br />
Additionally, a comprehensive training program for<br />
cardiac anesthesiologists has been developed for intraoperative<br />
transesophageal echocardiograms to enhance<br />
expertise <strong>and</strong> quality.<br />
Wayne Jones took our <strong>Heart</strong> CT Scan, was<br />
found to have plaque build-up <strong>and</strong> is now<br />
monitoring his diet <strong>and</strong> exercise along with<br />
medication to prevent a cardiac episode.<br />
19
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
Roy Pettijohn, quadruple<br />
bypass survivor, has seen<br />
the benefits of cardiac<br />
rehabilitation.<br />
20<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>
Wellness<br />
Rehabilitation<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center offers medically-supervised, individualized<br />
fitness <strong>and</strong> education programs that help patients reach personal health goals safely <strong>and</strong><br />
effectively. All of our staff, cardiac nurses, exercise physiologists <strong>and</strong> exercise specialists are<br />
advanced cardiac life support (ACLS) certified. In addition, onsite dietary education is provided<br />
by a dedicated registered dietitian.<br />
Research shows that cardiac rehabilitation program participants have a 20-25 percent reduced<br />
mortality rate from heart disease.<br />
Project <strong>Heart</strong> Restart<br />
Through Project <strong>Heart</strong> Restart, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> is working to reduce the number of deaths<br />
due to sudden cardiac arrest (SCA). Thanks to several generous grants, Project <strong>Heart</strong> ReStart<br />
has placed more than 70 new automated external defibrillators (AEDs) throughout Greater<br />
Cincinnati.<br />
<strong>Heart</strong> Aware Program<br />
<strong>The</strong> <strong>Heart</strong> Aware Program at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> offers a free online heart risk assessment.<br />
If participants are determined to be at high risk, a free follow-up appointment with a cardiac<br />
clinician is recommended to address their heart health concerns.<br />
<strong>Heart</strong> CT Scans<br />
For individuals looking for a more in-depth screening tool, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> offers<br />
discounted <strong>Heart</strong> CT Scans or calcium scoring tests.<br />
TCH C.A.R.E.S.<br />
With the increasing prevalence of vascular disease, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> has implemented a<br />
free vascular screening program for the Greater Cincinnati community. Screening for carotid,<br />
abdominal <strong>and</strong> peripheral blockages are performed throughout the Tristate.<br />
Community Partnerships & Education<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> offers multiple educational events throughout the year <strong>and</strong> partners with<br />
other not-for-profit organizations such as the American <strong>Heart</strong> Association, Cincinnati Sports<br />
Club <strong>and</strong> the Foundation for Female Awareness to increase community education.<br />
21
Medical Directors of <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center<br />
22<br />
Dean J. Kereiakes, M.D., F.A.C.C.<br />
Medical Director,<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong><br />
<strong>Vascular</strong> Center<br />
Dr. Kereiakes is the medical director of<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong><br />
Center <strong>and</strong> <strong>The</strong> Carl <strong>and</strong> Edyth Lindner<br />
Clinical Center; chairman of the executive<br />
committee for Ohio <strong>Heart</strong> & <strong>Vascular</strong><br />
Center, Inc.; <strong>and</strong> professor of clinical<br />
medicine at <strong>The</strong> Ohio State University.<br />
Dr. Kereiakes completed his undergraduate<br />
<strong>and</strong> medical education at the University of<br />
Cincinnati. He then completed a medical<br />
internship <strong>and</strong> residency at the University<br />
of California in San Francisco. He was a<br />
senior medical resident at Massachusetts<br />
General <strong>Hospital</strong> in Boston <strong>and</strong> returned<br />
to San Francisco (H.C. Moffitt <strong>Hospital</strong>),<br />
where he was chief resident. Dr. Kereiakes<br />
currently serves on multiple editorial<br />
boards for medical journals, including<br />
<strong>The</strong> Journal of American College of<br />
Cardiology, Circulation, American Journal<br />
of Cardiology, American <strong>Heart</strong> Journal <strong>and</strong><br />
Reviews in Cardiovascular Medicine. He<br />
has participated in more than 800 clinical<br />
research studies <strong>and</strong> has contributed<br />
more than 500 scientific publications in<br />
peer reviewed medical journals, abstracts<br />
<strong>and</strong> textbooks.<br />
Charles R. Hattemer, M.D.,<br />
F.A.C.C.<br />
Section Chief of Cardiology<br />
Dr. Hattemer is the section chief of<br />
cardiology <strong>and</strong> medical director of<br />
the cardiac catheterization lab at <strong>The</strong><br />
<strong>Christ</strong> <strong>Hospital</strong>, as well as a cardiologist<br />
with Greater Cincinnati Cardiovascular<br />
Consultants. After completing his<br />
undergraduate degree from Harvard<br />
University, he completed his medical<br />
degree at Case Western Reserve<br />
University School of Medicine in<br />
Clevel<strong>and</strong>, Ohio. He completed his<br />
internship, residency, <strong>and</strong> cardiology <strong>and</strong><br />
interventional fellowships at the University<br />
of Cincinnati Medical Center, including<br />
a year as chief resident. He has been<br />
associate professor <strong>and</strong> director of the<br />
cardiac care unit <strong>and</strong> of the fellowship<br />
training program at the University of<br />
Cincinnati. He is the founder of Medical<br />
Volunteers of Cincinnati.<br />
Richard B. Budde, Jr., M.D.<br />
Medical Director,<br />
Radiology<br />
Dr. Budde is the medical director of<br />
radiology at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>and</strong> has<br />
been a radiologist with Professional<br />
Radiology, Inc., since 1992. He completed<br />
his undergraduate degree at the University<br />
of Notre Dame <strong>and</strong> completed his medical<br />
degree at <strong>The</strong> University of Cincinnati<br />
College of Medicine. He completed an<br />
internship <strong>and</strong> residency at the St. Francis<br />
Medical Center in Pittsburgh, including<br />
one year as chief resident, <strong>and</strong> he<br />
completed a fellowship at the division of<br />
cardiovascular <strong>and</strong> interventional radiology<br />
at <strong>The</strong> Ohio State University in Columbus,<br />
Ohio. Dr. Budde is board certified in<br />
diagnostic radiology as well as vascular<br />
interventional radiology.<br />
Robert Bulas, M.D.,<br />
Medical Director,<br />
Neurointerventional Services<br />
Dr. Bulas has been the medical director of<br />
neurointerventional services at <strong>The</strong> <strong>Christ</strong><br />
<strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center for<br />
15 years as well as a neurointerventional<br />
radiologist with Professional Radiology,<br />
Inc. Dr. Bulas received his medical degree<br />
from the Ohio State University College<br />
of Medicine, in Columbus, Ohio. He<br />
completed his residency at the Medical<br />
College of Virginia, in Richmond, Virginia,<br />
<strong>and</strong> his fellowship in diagnostic <strong>and</strong><br />
interventional neuroradiology at the<br />
University of Cincinnati, in Cincinnati, Ohio.<br />
He has co-authored several publications,<br />
has served as principal investigator for<br />
numerous carotid stenting trials <strong>and</strong> is an<br />
investigator in many stroke treatment trials.<br />
Dr. Bulas specializes in prevention of stroke<br />
related to carotid artery disease, with an<br />
emphasis on multi-disciplinary teamwork<br />
within our Carotid Stroke Prevention Team.
Eugene Chung, M.D., F.A.C.C.<br />
Medical Director,<br />
Outcomes<br />
Dr. Chung received his Bachelor of<br />
Science degree from Yale University,<br />
<strong>and</strong> his medical degree from<br />
the University of Massachusetts<br />
Medical School. He completed<br />
his internal medicine residency at<br />
Mount Sinai Medical Center in New<br />
York City <strong>and</strong> his cardiovascular<br />
fellowship at the University of<br />
Massachusetts. Dr. Chung remained<br />
as an assistant professor of medicine<br />
in echocardiography <strong>and</strong> cardiac<br />
catheterization at the University of<br />
Massachusetts Medical School <strong>and</strong><br />
served as the associate director of<br />
their <strong>Heart</strong> Failure Program. In June<br />
2000, Dr. Chung moved to Cincinnati<br />
to serve as director of heart failure<br />
for <strong>The</strong> Ohio <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong><br />
Center <strong>and</strong> the Lindner Clinical Trial<br />
Center. In addition, he is currently the<br />
medical director of outcomes at <strong>The</strong><br />
<strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong><br />
Center. His research interests are<br />
in improving heart failure outcomes<br />
through device-based therapies <strong>and</strong><br />
innovative medical strategies; in this<br />
regard, he remains active in designing<br />
<strong>and</strong> conducting single-center <strong>and</strong><br />
multicenter clinical studies. Dr. Chung<br />
is board certified in cardiology.<br />
Gregory B. Clarke, M.D.,<br />
F.A.C.C.<br />
Associate Medical Director,<br />
Advanced Imaging<br />
Dr. Clarke specializes in clinical<br />
cardiology with subspecialty<br />
training in cardiac imaging including<br />
echocardiography, nuclear cardiology<br />
<strong>and</strong> cardiac CT. After completing his<br />
undergraduate degree in kinesiological<br />
sciences from <strong>The</strong> University of<br />
Maryl<strong>and</strong>, he obtained a master’s<br />
degree in exercise physiology. Dr.<br />
Clarke attended medical school at <strong>The</strong><br />
Indiana University School of Medicine<br />
in Indianapolis. He completed his<br />
internship, residency <strong>and</strong> chief<br />
residency in internal medicine at <strong>The</strong><br />
Indiana University School of Medicine.<br />
Dr. Clarke received his cardiology<br />
training as a fellow at <strong>The</strong> Indiana<br />
University School of Medicine <strong>and</strong><br />
<strong>The</strong> Krannert Institute of Cardiology.<br />
Dr. Clarke has served as a captain<br />
<strong>and</strong> physician in <strong>The</strong> Indiana Army<br />
National Guard from 1987 to 1994.<br />
Dr. Clarke is board certified in internal<br />
medicine, cardiovascular diseases,<br />
echocardiography <strong>and</strong> nuclear<br />
cardiology.<br />
Mark Harding, M.D., F.A.C.S.<br />
Medical Director,<br />
Wound Healing Center<br />
Mark Harding, M.D., is the medical<br />
director of <strong>The</strong> Wound Healing Center<br />
at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>and</strong> a vascular<br />
surgeon with Cranley Surgical<br />
Associates. Dr. Harding is certified by<br />
the America Board of Surgery in<br />
vascular surgery <strong>and</strong> is a fellow in the<br />
American College of Surgeons. He<br />
completed a general surgery residency<br />
<strong>and</strong> vascular surgery fellowship at the<br />
University of Utah. He also completed<br />
additional training in endovascular<br />
surgery at the Clevel<strong>and</strong> Clinic. Dr.<br />
Harding received his medical degree<br />
from Wright State University. Prior to<br />
joining Cranley Surgical Associates in<br />
2007, Dr. Harding practiced vascular<br />
surgery at the Marshfield Clinic in<br />
Marshfield, Wisconsin. Dr. Harding<br />
has a special interest in all aspects of<br />
vascular surgery including<br />
endovascular procedures <strong>and</strong><br />
angiography.<br />
Daniel E. Long, M.D.<br />
Medical Director,<br />
Interventional Radiology<br />
Dr. Long is the medical director of<br />
interventional radiology at <strong>The</strong> <strong>Christ</strong><br />
<strong>Hospital</strong> <strong>and</strong> has been a radiologist<br />
with Professional Radiology, Inc., since<br />
2001. He completed his undergraduate<br />
degree at <strong>The</strong> Ohio State University<br />
<strong>and</strong> went on to medical school at<br />
the University of Cincinnati College<br />
of Medicine. Dr. Long specializes in<br />
diagnostic <strong>and</strong> interventional radiology,<br />
<strong>and</strong> is board certified in radiology. He<br />
completed his residency in diagnostic<br />
radiology at <strong>The</strong> Ohio State University<br />
Medical Center, including one year<br />
as chief resident, <strong>and</strong> completed his<br />
fellowship in interventional radiology at<br />
Johns Hopkins <strong>Hospital</strong> in Baltimore.<br />
He has published numerous scientific<br />
abstracts <strong>and</strong> has been president-elect<br />
for the Ohio Resident Physician Section<br />
of the Ohio State Radiological Society<br />
as well as a finalist for the International<br />
Society for Magnetic Resonance in<br />
their Medicine Fellowship Program.<br />
Wojciech Mazur, M.D.,<br />
F.A.C.C.<br />
Medical Director,<br />
Advanced Imaging<br />
Dr. Mazur is the medical director of<br />
advanced imaging at <strong>The</strong> <strong>Christ</strong><br />
<strong>Hospital</strong> <strong>and</strong> is a cardiologist with Ohio<br />
<strong>Heart</strong> & <strong>Vascular</strong> Center, Inc. Dr. Mazur<br />
specializes in cardiovascular imaging,<br />
including cardiovascular CT <strong>and</strong> MR.<br />
He received his medical education at<br />
the Medical Academy in Poznan,<br />
Pol<strong>and</strong>. He then completed a postdoctoral<br />
fellowship in molecular <strong>and</strong><br />
experimental cardiology at Baylor<br />
College of Medicine in Texas. This was<br />
followed by an internship <strong>and</strong> residency<br />
in internal medicine, also at Baylor<br />
College of Medicine, where he served<br />
as chief resident. He then completed a<br />
three-year cardiology fellowship at<br />
Baylor. Prior to joining Ohio <strong>Heart</strong>, Dr.<br />
Mazur served as assistant professor of<br />
cardiology at Wake Forest University in<br />
North Carolina. Dr. Mazur is one of very<br />
few cardiologists in this area trained in<br />
cardiac MRI <strong>and</strong> CT scanning. He is<br />
board certified in internal medicine,<br />
cardiovascular diseases,<br />
echocardiography <strong>and</strong> nuclear 23<br />
cardiology. Dr. Mazur is an<br />
associate professor of clinical<br />
medicine at the University of<br />
Cincinnati. He has authored/coauthored<br />
more than 70 publications.
Medical Directors of <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center<br />
24<br />
Santosh G. Menon, M.B.B.S.,<br />
M.D., F.A.C.C.<br />
Associate Medical Director,<br />
Congestive <strong>Heart</strong> Failure<br />
Dr. Menon is the associate medical director<br />
of congestive heart failure at <strong>The</strong> <strong>Christ</strong><br />
<strong>Hospital</strong>, is a cardiologist with the Ohio<br />
<strong>Heart</strong> & <strong>Vascular</strong> Center, Inc., <strong>and</strong> is codirector<br />
of the Congestive <strong>Heart</strong> Failure<br />
Program for Ohio <strong>Heart</strong>. Dr. Menon is<br />
a graduate of the TD Medical College<br />
in Kerala, India. He came to the United<br />
States to complete an internship <strong>and</strong><br />
residency in internal medicine with the<br />
Robert Wood Johnson Medical School<br />
at St. Peter’s Medical Center in New<br />
Brunswick, New Jersey, where he also<br />
served as chief medical resident. He then<br />
completed a fellowship in heart failure <strong>and</strong><br />
cardiac transplantation at the University<br />
of Utah Health Sciences Center. Prior to<br />
joining Ohio <strong>Heart</strong> in 2001, Dr. Menon<br />
served as co-director of the Congestive<br />
<strong>Heart</strong> Failure <strong>and</strong> Cardiac Transplantation<br />
Program at University of Cincinnati College<br />
of Medicine, where he also directed<br />
the fellowship program. Dr. Menon has<br />
authored numerous publications on heart<br />
failure treatment.<br />
Stephen M. Meyers, M.D.<br />
Medical Director,<br />
Wellness Center<br />
Dr. Meyers is the medical director of<br />
the cardiovascular wellness program at<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong><br />
Center <strong>and</strong> is a cardiologist with Greater<br />
Cincinnati Cardiovascular Consultants, Inc.<br />
He completed his undergraduate degree<br />
at the University of Notre Dame as well<br />
as a post-baccalaureate degree at Xavier<br />
University. Dr. Meyers received his<br />
medical degree at <strong>The</strong> University of<br />
Cincinnati College of Medicine. He then<br />
completed a residency at the University<br />
of North Carolina <strong>Hospital</strong>s where he<br />
received the Resident Teaching Award for<br />
internal medicine. He also completed a<br />
fellowship at the University of Cincinnati,<br />
department of cardiology. Dr. Meyers is<br />
board certified in internal medicine <strong>and</strong><br />
cardiovascular disease.<br />
Donald L. Mitts, M.D., F.A.C.C.,<br />
F.A.C.S.<br />
Medical Director,<br />
Cardiac Surgery<br />
Dr. Mitts is the medical director of<br />
cardiac surgery at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
<strong>and</strong> is a cardiac surgeon with Ohio<br />
<strong>Heart</strong> & <strong>Vascular</strong> Center, Inc. Dr. Mitts<br />
completed his undergraduate <strong>and</strong><br />
medical education at the University of<br />
Kentucky (UK) in Lexington. He then<br />
completed a surgical internship at UK,<br />
before moving to San Antonio, Texas,<br />
to complete a residency in general <strong>and</strong><br />
thoracic surgery at the University of<br />
Texas. He also has completed training for<br />
the Eclipse Holmium Laser to perform<br />
transmyocardial revascularization (TMR).<br />
Before joining Ohio <strong>Heart</strong> in 2002,<br />
Dr. Mitts’ career spans 25 years as a<br />
cardiac surgeon in Cincinnati. Dr. Mitts<br />
is board-certified by both the American<br />
Board of Surgery <strong>and</strong> the Board of<br />
Thoracic Surgery, <strong>and</strong> is a fellow in the<br />
American College of Cardiology as well as<br />
the American College of Surgeons.<br />
Steven Park, M.D.<br />
Medical Director,<br />
Robotics<br />
Dr. Park is the medical director of robotic<br />
surgery at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong><br />
<strong>and</strong> <strong>Vascular</strong> Center <strong>and</strong> a general <strong>and</strong><br />
cardiothoracic surgeon with<br />
Cardiovascular <strong>and</strong> Thoracic Surgeons,<br />
Inc. Dr. Park received his medical degree<br />
from the University of Chicago Pritzker<br />
School of Medicine. He then completed<br />
an internship <strong>and</strong> his residency in general<br />
surgery at the University of Iowa. His<br />
residency in thoracic surgery was<br />
completed at the Allegheny General<br />
<strong>Hospital</strong>, Philadelphia, Pennsylvania.<br />
Dr. Park also completed special training in<br />
thoracoabdominal aneurysm repair at the<br />
University of Texas at Houston.
Peter C. Podore, M.D., F.A.C.S.<br />
Section Chief,<br />
<strong>Vascular</strong> Surgery<br />
Dr. Podore is the section chief of vascular<br />
surgery at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>, as well<br />
as the president <strong>and</strong> medical director of<br />
Midwest Ultrasound, one of the largest<br />
cardiovascular diagnostic ultrasound<br />
services in the country. He maintains a<br />
private practice at <strong>Christ</strong> <strong>Hospital</strong>.<br />
Dr. Podore received his bachelor’s<br />
degree from Williams College <strong>and</strong> his<br />
medical degree <strong>and</strong> surgical training at<br />
the University of Rochester. Dr. Podore<br />
is board certified in vascular surgery<br />
by the American Board of Surgery, <strong>and</strong><br />
is certified as a Registered Physician<br />
<strong>Vascular</strong> Interpreter (RPVI) by the<br />
American Registry of Diagnostic Medical<br />
Sonographers. He is also a Fellow of<br />
the American College of Surgeons,<br />
past president of the Cincinnati Surgical<br />
Society <strong>and</strong> a member of regional <strong>and</strong><br />
national vascular surgery societies.<br />
Dr. Podore has authored numerous<br />
vascular-related articles.<br />
John Paul Runyon, M.D., F.A.C.C.<br />
Medical Director,<br />
<strong>Vascular</strong> Center<br />
Dr. Runyon is the medical director of the<br />
<strong>Vascular</strong> Center at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>and</strong><br />
is a cardiologist with Ohio <strong>Heart</strong> <strong>and</strong><br />
<strong>Vascular</strong> Center. Dr. Runyon received his<br />
undergraduate degree from Transylvania<br />
University in Lexington, Kentucky. He<br />
completed his medical degree at the<br />
University of Kentucky School of Medicine.<br />
He then interned at the University of<br />
Cincinnati Medical Center (UC), where he<br />
also completed his residency. Dr. Runyon<br />
completed two fellowships at UC in<br />
cardiology <strong>and</strong> interventional cardiology.<br />
He is board certified in cardiovascular<br />
disease <strong>and</strong> interventional cardiology.<br />
Dr. Runyon has held positions as associate<br />
professor of medicine at the University of<br />
Cincinnati, director of the cardiac<br />
catheterization lab at UC <strong>and</strong> director of<br />
the coronary care unit. Dr. Runyon<br />
participates in numerous clinical research<br />
trials <strong>and</strong> has contributed to many<br />
publications on his findings.<br />
Ian Sarembock, M.B., Ch.B., M.D.,<br />
F.A.C.C.<br />
Associate Medical Director,<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong><br />
Center<br />
Dr. Sarembock received both his medical<br />
degree (MB, ChB, 1975) <strong>and</strong> doctorate in<br />
cardiology (MD, 1988) from the University of<br />
Cape Town (U.C.T.). He completed his<br />
internal medicine residency <strong>and</strong> clinical <strong>and</strong><br />
research cardiology fellowship at Groote<br />
Schuur <strong>Hospital</strong> in 1986. He then moved to<br />
the United States <strong>and</strong> became a research<br />
associate at Yale University. In 1988, he<br />
accepted the directorship of the coronary<br />
care unit at the University of Virginia (UVA),<br />
where he served for nearly 19 years, most<br />
recently as the Harrison Distinguished<br />
Teaching Professor of Medicine <strong>and</strong> director<br />
of the Center for Interventional Cardiology.<br />
His research career has spanned from basic<br />
science to clinical trials with more than 250<br />
publications. He is a peer reviewer for many<br />
clinical <strong>and</strong> investigational cardiovascular<br />
medicine journals. Dr. Sarembock is a<br />
cardiologist with Ohio <strong>Heart</strong> & <strong>Vascular</strong><br />
Center <strong>and</strong> is board certified in cardiovascular<br />
disease <strong>and</strong> interventional cardiology.<br />
Edward J. Schloss, M.D., F.A.C.C.<br />
Medical Director,<br />
Electrophysiology<br />
Dr. Schloss is the medical director of<br />
electrophysiology at <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
<strong>and</strong> has been a cardiologist with the<br />
Ohio <strong>Heart</strong> & <strong>Vascular</strong> Center, Inc., since<br />
1997. He completed his undergraduate<br />
degree with honors from Northwestern<br />
University in Evanston, Illinois, <strong>and</strong> also<br />
received his medical degree from the<br />
Northwestern University Medical School.<br />
He completed an internship, residency<br />
<strong>and</strong> fellowship in cardiovascular diseases<br />
at University of Pittsburgh Medical<br />
Center, as well as a fellowship in cardiac<br />
electrophysiology at the Clevel<strong>and</strong> Clinic<br />
Foundation. Dr. Schloss has a wealth of<br />
research experience <strong>and</strong> has published<br />
a variety of cardiology-related articles<br />
in such publications as the Journal of<br />
the American College of Cardiology <strong>and</strong><br />
Pacing <strong>and</strong> Cardiac Electrophysiology.<br />
25
An Award Winning <strong>Hospital</strong><br />
Cardiac Care<br />
2008, Greater Cincinnati Health Council’s Best Innovative Healthcare<br />
Solutions for <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> Link Program (Honorable Mention)<br />
2000-2008, Selected annually as one of America’s Best <strong>Hospital</strong>s: Top 50<br />
in <strong>Heart</strong> & <strong>Heart</strong> Surgery, U.S.News & World Report<br />
2007, <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center physicians from the<br />
Ohio <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center <strong>and</strong> <strong>The</strong> Lindner Clinical Trials Center<br />
presented the results from late-breaking, multi-center clinical trials at<br />
the American <strong>Heart</strong> Association meeting (<strong>The</strong>odore Chow, M.D., for the<br />
MASTER-1 Trial), Transcatheter Cardiovascualr <strong>The</strong>rapeutics meeting<br />
(Dean Kereiakes, M.D., for the AMETHYST Trial) <strong>and</strong> <strong>The</strong> <strong>Heart</strong> Failure<br />
Society of America (Eugene Chung, M.D. for the PROSPECT Trial).<br />
2007, <strong>Heart</strong> Center named Anthem’s Ohio <strong>Hospital</strong> Quality Program’s<br />
Successful Practice Award for “Minimizing Time Delays to Percutaneous<br />
Coronary Intervention (PCI) in a Community <strong>Hospital</strong>.”<br />
2007, Anthem Blue Distinction Center for Cardiac Care<br />
2007, VHA Leadership award for the <strong>Heart</strong> Attack Program<br />
2007, 2005, <strong>Christ</strong> <strong>Hospital</strong> Named UnitedHealth Premium Cardiac<br />
Specialty Center<br />
<strong>The</strong> United Health Premium cardiac specialty centers program identifies<br />
hospitals nationwide that are leaders in providing cardiac care.<br />
1999-2006, Selected annually as Top 100 Cardiovascular <strong>Hospital</strong>s in the<br />
US presented by Solucient (formerly presented by HCIA-Sachs).<br />
1998, Top <strong>Hospital</strong> in Cincinnati for Overall Cardiology Services<br />
Presented by HCIA, Inc. <strong>and</strong> America’s Health Network (No longer awarded)<br />
1999, Consumer Choice Award, <strong>Heart</strong> Care Services<br />
Greater Cincinnati’s Most Preferred <strong>Hospital</strong> for <strong>Heart</strong> Care Services<br />
presented by National Research Corporation. (No longer awarded)<br />
Overall Quality<br />
2007, Ohio <strong>Hospital</strong> Association Safety Award<br />
2005, Ernest Armory Codman Award<br />
<strong>The</strong> Joint Commission on Accreditation of Healthcare Organizations<br />
named the Greater Cincinnati Patient Safety ICU Collaborative, including<br />
member <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong>, a 2005 recipient of the ninth annual Ernest<br />
Amory Codman Award to recognize excellence in the use of outcomes<br />
measurement by health care organizations to achieve improvements in<br />
the quality <strong>and</strong> safety of health care.<br />
1996-2007, Selected annually as Most Preferred <strong>Hospital</strong> for Overall<br />
Healthcare Services.<br />
Presented by National Research Corporation.<br />
2001, Top 100 <strong>Hospital</strong>s. Presented by Thompson, (formerly Solucient)<br />
1998, 2000, Top <strong>Hospital</strong> in Cincinnati for Overall Performance.<br />
Presented by HCIA, Inc. <strong>and</strong> America’s Health Network.<br />
26
How to Reach Us<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong> <strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center<br />
<strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center Information<br />
513-585-1000<br />
Patient Transfers<br />
513-585-2337<br />
<strong>The</strong> Lindner Clinical Trial Center<br />
513-585-1777<br />
<strong>Heart</strong> Aware Risk Assessment<br />
513-585-4700<br />
<strong>Heart</strong> Scan<br />
513-585-2668<br />
<strong>Vascular</strong> Screenings<br />
513-936-5291<br />
General Information about <strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
513-585-2000<br />
www.<strong>The</strong><strong>Christ</strong><strong>Hospital</strong>.com<br />
27
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
2139 Auburn Avenue<br />
Cincinnati, Ohio 45219<br />
Non Profit Org.<br />
US Postage<br />
PAID<br />
Cincinnati, OH<br />
Permit # 5489<br />
<strong>The</strong> <strong>Christ</strong> <strong>Hospital</strong><br />
<strong>Heart</strong> <strong>and</strong> <strong>Vascular</strong> Center SM<br />
Annual Report / 2008